TriSalus Life Sciences, Inc. TLSI Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s total current liabilities?
- TriSalus Life Sciences, Inc. (TLSI) reported total current liabilities of $11.79M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s total current liabilities changed year-over-year?
- TriSalus Life Sciences, Inc.'s total current liabilities increased by 0.3% year-over-year, from $11.75M to $11.79M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s total current liabilities?
- Over 4 years (2021 to 2025), TriSalus Life Sciences, Inc.'s total current liabilities has grown at a 63.7% compound annual growth rate (CAGR), from $1.6M to $11.5M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.